Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study - Scorecard - MDSpire

Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study

  • By

  • Guillermo Quintero

  • Sandra Aruachan

  • Jair Figueroa Emiliani

  • Kenny Galvez

  • Luis Antonio Salazar

  • Constanza Otero Venegas

  • Diana Buitrago

  • Humberto Martínez-Cordero

  • Juliana Saavedra

  • Maria Fernanda Vargas

  • July 1, 2026

  • 0 min

Share

Clinical Scorecard: Clinical Characteristics and Treatment Approaches in Colombian Patients with Second Relapse of Multiple Myeloma: Findings from a Multicenter Observational Study

At a Glance

CategoryDetail
ConditionMultiple Myeloma
Key MechanismsMalignant disorder of plasma cells leading to excessive monoclonal immunoglobulin production and organ damage.
Target PopulationPatients with Multiple Myeloma experiencing a second relapse.
Care SettingRoutine clinical practice across five specialized institutions in Colombia.

Key Highlights

  • Remove any implications about treatment efficacy or outcomes that are not directly supported by the source.

Guideline-Based Recommendations

Diagnosis

    Management

    • Ensure that management recommendations are strictly based on the source without implying clinical implications.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        84 patients with Multiple Myeloma experiencing a second relapse.

        Diverse treatment patterns with increasing use of novel agents in third-line therapy.

        Clinical Best Practices

        • Revise to ensure practices are stated as observations rather than recommendations.

        Related Resources & Content

        Original Source(s)

        Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study

        • by Guillermo Quintero, Sandra Aruachan, Jair Figueroa Emiliani, Kenny Galvez, Luis Antonio Salazar, Constanza Otero Venegas, Diana Buitrago, Humberto Martínez-Cordero, Juliana Saavedra, Maria Fernanda Vargas

        • July 1, 2026

        Related Content

        Life-threatening multiorgan immune-related toxicities complicated by sepsis after anti-PD-1 therapy with complete tumor regression: a case report and literature review

        Development and validation of a prediction model for psychological distress in patients with differentiated thyroid cancer undergoing ¹³¹I therapy

        Established and emerging prognostic factors in mycosis fungoides and Sézary syndrome